Companion Animal Ear Infection Treatment Market (By Product: Anti-bacterial, Anti-fungal, Corticosteroids, Other; By Disease Type: Otitis Externa, Otitis Media, Otitis Interna; By Mode of Administration: Topical, Oral, Otic; By Animal Type: Dogs, Cats, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030

Published Date : Aug 2021 | No. of Pages : 150+ Pages | Category : Healthcare


Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Companion Animal Ear Infection Treatment Market, By Product

7.1.  Companion Animal Ear Infection Treatment Market, by Product, 2020-2030

7.1.1.    Anti-bacterial

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    Anti-fungal

7.1.2.1.        Market Revenue and Forecast (2016-2030)

7.1.3.    Corticosteroids

7.1.3.1.        Market Revenue and Forecast (2016-2030)

7.1.4.    Others

7.1.4.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Companion Animal Ear Infection Treatment Market, By Disease Type

8.1.  Companion Animal Ear Infection Treatment Market, by Disease Type, 2020-2030

8.1.1.    Otitis Externa

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Otitis Media

8.1.2.1.        Market Revenue and Forecast (2016-2030)

8.1.3.    Otitis Interna

8.1.3.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global Companion Animal Ear Infection Treatment Market, By Mode of Administration

9.1.  Companion Animal Ear Infection Treatment Market, by Mode of Administration, 2020-2030

9.1.1.    Topical

9.1.1.1.        Market Revenue and Forecast (2016-2030)

9.1.2.    Oral

9.1.2.1.        Market Revenue and Forecast (2016-2030)

9.1.3.    Otic

9.1.3.1.        Market Revenue and Forecast (2016-2030)

Chapter 10.      Global Companion Animal Ear Infection Treatment Market, By Animal Type

10.1.        Companion Animal Ear Infection Treatment Market, by Animal Type, 2020-2030

10.1.1.  Dogs

10.1.1.1.      Market Revenue and Forecast (2016-2030)

10.1.2.  Cats

10.1.2.1.      Market Revenue and Forecast (2016-2030)

10.1.3.  Others

10.1.3.1.      Market Revenue and Forecast (2016-2030)

Chapter 11.      Global Companion Animal Ear Infection Treatment Market, Regional Estimates and Trend Forecast

11.1.        North America

11.1.1.  Market Revenue and Forecast, by Product (2016-2030)

11.1.2.  Market Revenue and Forecast, by Disease Type (2016-2030)

11.1.3.  Market Revenue and Forecast, by Mode of Administration (2016-2030)

11.1.4.  Market Revenue and Forecast, by Animal Type (2016-2030)

11.1.5.  U.S.

11.1.5.1.      Market Revenue and Forecast, by Product (2016-2030)

11.1.5.2.      Market Revenue and Forecast, by Disease Type (2016-2030)

11.1.5.3.      Market Revenue and Forecast, by Mode of Administration (2016-2030)

11.1.5.4.      Market Revenue and Forecast, by Animal Type (2016-2030)

11.1.6.  Rest of North America

11.1.6.1.      Market Revenue and Forecast, by Product (2016-2030)

11.1.6.2.      Market Revenue and Forecast, by Disease Type (2016-2030)

11.1.6.3.      Market Revenue and Forecast, by Mode of Administration (2016-2030)

11.1.6.4.      Market Revenue and Forecast, by Animal Type (2016-2030)

11.2.        Europe

11.2.1.  Market Revenue and Forecast, by Product (2016-2030)

11.2.2.  Market Revenue and Forecast, by Disease Type (2016-2030)

11.2.3.  Market Revenue and Forecast, by Mode of Administration (2016-2030)

11.2.4.  Market Revenue and Forecast, by Animal Type (2016-2030)

11.2.5.  UK

11.2.5.1.      Market Revenue and Forecast, by Product (2016-2030)

11.2.5.2.      Market Revenue and Forecast, by Disease Type (2016-2030)

11.2.5.3.      Market Revenue and Forecast, by Mode of Administration (2016-2030)

11.2.5.4.      Market Revenue and Forecast, by Animal Type (2016-2030)

11.2.6.  Germany

11.2.6.1.      Market Revenue and Forecast, by Product (2016-2030)

11.2.6.2.      Market Revenue and Forecast, by Disease Type (2016-2030)

11.2.6.3.      Market Revenue and Forecast, by Mode of Administration (2016-2030)

11.2.6.4.      Market Revenue and Forecast, by Animal Type (2016-2030)

11.2.7.  France

11.2.7.1.      Market Revenue and Forecast, by Product (2016-2030)

11.2.7.2.      Market Revenue and Forecast, by Disease Type (2016-2030)

11.2.7.3.      Market Revenue and Forecast, by Mode of Administration (2016-2030)

11.2.7.4.      Market Revenue and Forecast, by Animal Type (2016-2030)

11.2.8.  Rest of Europe

11.2.8.1.      Market Revenue and Forecast, by Product (2016-2030)

11.2.8.2.      Market Revenue and Forecast, by Disease Type (2016-2030)

11.2.8.3.      Market Revenue and Forecast, by Mode of Administration (2016-2030)

11.2.8.4.      Market Revenue and Forecast, by Animal Type (2016-2030)

11.3.        APAC

11.3.1.  Market Revenue and Forecast, by Product (2016-2030)

11.3.2.  Market Revenue and Forecast, by Disease Type (2016-2030)

11.3.3.  Market Revenue and Forecast, by Mode of Administration (2016-2030)

11.3.4.  Market Revenue and Forecast, by Animal Type (2016-2030)

11.3.5.  India

11.3.5.1.      Market Revenue and Forecast, by Product (2016-2030)

11.3.5.2.      Market Revenue and Forecast, by Disease Type (2016-2030)

11.3.5.3.      Market Revenue and Forecast, by Mode of Administration (2016-2030)

11.3.5.4.      Market Revenue and Forecast, by Animal Type (2016-2030)

11.3.6.  China

11.3.6.1.      Market Revenue and Forecast, by Product (2016-2030)

11.3.6.2.      Market Revenue and Forecast, by Disease Type (2016-2030)

11.3.6.3.      Market Revenue and Forecast, by Mode of Administration (2016-2030)

11.3.6.4.      Market Revenue and Forecast, by Animal Type (2016-2030)

11.3.7.  Japan

11.3.7.1.      Market Revenue and Forecast, by Product (2016-2030)

11.3.7.2.      Market Revenue and Forecast, by Disease Type (2016-2030)

11.3.7.3.      Market Revenue and Forecast, by Mode of Administration (2016-2030)

11.3.7.4.      Market Revenue and Forecast, by Animal Type (2016-2030)

11.3.8.  Rest of APAC

11.3.8.1.      Market Revenue and Forecast, by Product (2016-2030)

11.3.8.2.      Market Revenue and Forecast, by Disease Type (2016-2030)

11.3.8.3.      Market Revenue and Forecast, by Mode of Administration (2016-2030)

11.3.8.4.      Market Revenue and Forecast, by Animal Type (2016-2030)

11.4.        MEA

11.4.1.  Market Revenue and Forecast, by Product (2016-2030)

11.4.2.  Market Revenue and Forecast, by Disease Type (2016-2030)

11.4.3.  Market Revenue and Forecast, by Mode of Administration (2016-2030)

11.4.4.  Market Revenue and Forecast, by Animal Type (2016-2030)

11.4.5.  GCC

11.4.5.1.      Market Revenue and Forecast, by Product (2016-2030)

11.4.5.2.      Market Revenue and Forecast, by Disease Type (2016-2030)

11.4.5.3.      Market Revenue and Forecast, by Mode of Administration (2016-2030)

11.4.5.4.      Market Revenue and Forecast, by Animal Type (2016-2030)

11.4.6.  North Africa

11.4.6.1.      Market Revenue and Forecast, by Product (2016-2030)

11.4.6.2.      Market Revenue and Forecast, by Disease Type (2016-2030)

11.4.6.3.      Market Revenue and Forecast, by Mode of Administration (2016-2030)

11.4.6.4.      Market Revenue and Forecast, by Animal Type (2016-2030)

11.4.7.  South Africa

11.4.7.1.      Market Revenue and Forecast, by Product (2016-2030)

11.4.7.2.      Market Revenue and Forecast, by Disease Type (2016-2030)

11.4.7.3.      Market Revenue and Forecast, by Mode of Administration (2016-2030)

11.4.7.4.      Market Revenue and Forecast, by Animal Type (2016-2030)

11.4.8.  Rest of MEA

11.4.8.1.      Market Revenue and Forecast, by Product (2016-2030)

11.4.8.2.      Market Revenue and Forecast, by Disease Type (2016-2030)

11.4.8.3.      Market Revenue and Forecast, by Mode of Administration (2016-2030)

11.4.8.4.      Market Revenue and Forecast, by Animal Type (2016-2030)

11.5.        Latin America

11.5.1.  Market Revenue and Forecast, by Product (2016-2030)

11.5.2.  Market Revenue and Forecast, by Disease Type (2016-2030)

11.5.3.  Market Revenue and Forecast, by Mode of Administration (2016-2030)

11.5.4.  Market Revenue and Forecast, by Animal Type (2016-2030)

11.5.5.  Brazil

11.5.5.1.      Market Revenue and Forecast, by Product (2016-2030)

11.5.5.2.      Market Revenue and Forecast, by Disease Type (2016-2030)

11.5.5.3.      Market Revenue and Forecast, by Mode of Administration (2016-2030)

11.5.5.4.      Market Revenue and Forecast, by Animal Type (2016-2030)

11.5.6.  Rest of LATAM

11.5.6.1.      Market Revenue and Forecast, by Product (2016-2030)

11.5.6.2.      Market Revenue and Forecast, by Disease Type (2016-2030)

11.5.6.3.      Market Revenue and Forecast, by Mode of Administration (2016-2030)

11.5.6.4.      Market Revenue and Forecast, by Animal Type (2016-2030)

Chapter 12.  Company Profiles

12.1.              Zoetis

12.1.1.  Company Overview

12.1.2.  Product Offerings

12.1.3.  Financial Performance

12.1.4.  Recent Initiatives

12.2.              Elanco

12.2.1.  Company Overview

12.2.2.  Product Offerings

12.2.3.  Financial Performance

12.2.4.  Recent Initiatives

12.3.              Dechra Pharmaceuticals

12.3.1.  Company Overview

12.3.2.  Product Offerings

12.3.3.  Financial Performance

12.3.4.  Recent Initiatives

12.4.              Merck & Co., Inc.

12.4.1.  Company Overview

12.4.2.  Product Offerings

12.4.3.  Financial Performance

12.4.4.  Recent Initiatives

12.5.              Vetoquinol

12.5.1.  Company Overview

12.5.2.  Product Offerings

12.5.3.  Financial Performance

12.5.4.  Recent Initiatives

12.6.              Penn Veterinary Supply, Inc.

12.6.1.  Company Overview

12.6.2.  Product Offerings

12.6.3.  Financial Performance

12.6.4.  Recent Initiatives

12.7.              Virbac S.A.

12.7.1.  Company Overview

12.7.2.  Product Offerings

12.7.3.  Financial Performance

12.7.4.  Recent Initiatives

12.8.              Ceva Santé Animale

12.8.1.  Company Overview

12.8.2.  Product Offerings

12.8.3.  Financial Performance

12.8.4.  Recent Initiatives

12.9.              Vedco, Inc.

12.9.1.  Company Overview

12.9.2.  Product Offerings

12.9.3.  Financial Performance

12.9.4.  Recent Initiatives

Chapter 13.  Research Methodology

13.1.              Primary Research

13.2.              Secondary Research

13.3.              Assumptions

Chapter 14.  Appendix

14.1.              About Us

Glossary of Terms

Featured Research Reports

  • Featured Research Reports

    Medical Digital Imaging Systems Market (By Type: X-ray, MRI, Ultrasound, CT, Nuclear Imaging; By Technology: 2D, 3D/4D) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    U.S. Pharmacy Benefit Management Market (By Business Model: Standalone, Health Insurance Providers, Retail Pharmacy; By End Use: Commercial, Federal) - Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    U.S. In Vitro Diagnostics Market (By Product: Reagents, Instruments; By Technology: Immunoassay, Molecular Diagnostics; By Application: Infectious Diseases, Diabetes, Oncology, Cardiology; By End User: Hospitals, Laboratories, Home-care, Others) - Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    U.S. Clinical Trials Market (By Phase: Phase I, II, III, IV; By Study Design: Interventional, Observational; By Indication: Oncology, Diabetes) - Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    Compounding Pharmacies Market (By Therapeutic Area: Hormone Replacement, Pain Management, Dermatology Applications, Specialty Drugs, Nutritional Supplements; By Product: Oral, Liquid Preparations, Topical, Rectal, Others; By Application: Pediatric, Adult, Geriatric, Veterinary; By Compounding Type: PIA, CUPM, PDA; By Sterility: Sterile, Non-sterile; By Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022 – 2030

    Read more...